Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 401: Which of the following is contraindicated in a patient with Myasthenia Gravis?

A. Aminoglycosides (Correct Answer)
B. Sulfonamides
C. Penicillin
D. All the above

Explanation: **Explanation:** **1. Why Aminoglycosides are Contraindicated:** Myasthenia Gravis (MG) is an autoimmune disorder characterized by antibodies against nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction (NMJ), leading to muscle weakness. **Aminoglycosides** (e.g., Gentamicin, Neomycin, Streptomycin) are known to exacerbate MG because they interfere with neuromuscular transmission via two mechanisms: * **Presynaptic inhibition:** They inhibit the release of Acetylcholine (ACh) from the motor nerve terminal by competing with Calcium ions at the voltage-gated calcium channels. * **Postsynaptic blockade:** They decrease the sensitivity of the postsynaptic membrane to ACh. In a patient already lacking functional receptors, this further reduction in ACh release can precipitate a life-threatening **Myasthenic Crisis**. **2. Why other options are incorrect:** * **Sulfonamides and Penicillins:** These classes of antibiotics do not interfere with the neuromuscular junction or calcium signaling. They are generally considered safe for use in patients with Myasthenia Gravis. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Other Drugs to Avoid in MG:** * **Antibiotics:** Fluoroquinolones (Ciprofloxacin), Macrolides (Erythromycin), and Telithromycin. * **Cardiovascular Drugs:** Beta-blockers, Quinidine, Procainamide, and Calcium Channel Blockers. * **Neuromuscular Blockers:** Both depolarizing (Succinylcholine) and non-depolarizing (Vecuronium) agents must be used with extreme caution. * **Magnesium salts:** High magnesium levels inhibit ACh release. * **Management Tip:** If a patient on aminoglycosides develops respiratory distress, **Intravenous Calcium Gluconate** can partially reverse the neuromuscular blockade by antagonizing the inhibitory effect on calcium channels.

Question 402: The Edrophonium test is helpful in diagnosing which of the following conditions?

A. Marcus Gunn jaw winking ptosis
B. Myasthenia gravis (Correct Answer)
C. Blepharophimosis syndrome
D. Parkinson's disease

Explanation: **Explanation:** **Myasthenia Gravis (MG)** is an autoimmune disorder characterized by antibodies against nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, leading to muscle weakness and fatigue. **Edrophonium** is a very short-acting acetylcholinesterase inhibitor. When administered intravenously, it prevents the breakdown of acetylcholine, increasing its concentration at the synaptic cleft. This temporarily overcomes the competitive blockade of receptors, leading to a rapid, transient improvement in muscle strength (e.g., resolution of ptosis). This is known as the **Tensilon Test**. **Analysis of Incorrect Options:** * **Marcus Gunn jaw winking ptosis:** This is a congenital synkinetic ptosis caused by misdirected innervation of the trigeminal nerve to the levator muscle. It is a structural/neurological miswiring, not a neurotransmission defect, so it does not respond to Edrophonium. * **Blepharophimosis syndrome:** This is a rare genetic developmental disorder affecting the eyelids (ptosis, epicanthus inversus). As a structural/genetic deformity, it lacks the biochemical basis for response to anticholinesterases. * **Parkinson’s disease:** This is a neurodegenerative disorder involving dopamine deficiency in the basal ganglia. Treatment involves dopaminergic agents (Levodopa), not peripheral cholinergic enhancement. **High-Yield Clinical Pearls for NEET-PG:** * **Duration of Action:** Edrophonium has a very short half-life (approx. 10 minutes), making it ideal for diagnostic testing but unsuitable for therapy. * **Cholinergic Crisis vs. Myasthenic Crisis:** Edrophonium is used to differentiate these. If strength improves, it is a Myasthenic crisis (needs more drug); if strength worsens, it is a Cholinergic crisis (overdose). * **Antidote:** Always keep **Atropine** ready during the test to counteract potential bradycardia or excessive salivation. * **Current Status:** The Edrophonium test is largely replaced by the **Ice Pack Test** (highly sensitive for ptosis) and **Anti-AChR antibody titers** due to the risk of cardiac side effects.

Question 403: Hyoscine is which of the following?

A. Muscarinic antagonist (Correct Answer)
B. Nicotinic antagonist
C. Both muscarinic and nicotinic antagonist
D. None of the above

Explanation: **Explanation:** **Hyoscine (Scopolamine)** is a naturally occurring alkaloid derived from the Belladonna plant. It belongs to the class of **Anticholinergic drugs**, specifically acting as a **competitive Muscarinic antagonist**. 1. **Why Option A is Correct:** Hyoscine works by competitively blocking the action of acetylcholine at muscarinic receptors ($M_1$ to $M_5$). Unlike atropine, hyoscine has more potent central effects because it crosses the blood-brain barrier more readily. Its primary clinical utility stems from its action on $M_1$ receptors in the vestibular apparatus and the vomiting center. 2. **Why Other Options are Incorrect:** * **Option B & C:** Nicotinic antagonists (like Hexamethonium or Atracurium) target nicotinic receptors at autonomic ganglia ($N_n$) or the neuromuscular junction ($N_m$). Hyoscine has negligible affinity for these receptors at therapeutic doses; therefore, it does not cause significant ganglionic or neuromuscular blockade. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Motion Sickness:** Hyoscine is the most effective agent for preventing motion sickness. It is typically administered as a **transdermal patch** applied behind the ear (pinna) to ensure slow, sustained absorption. * **Amnesic Effect:** It produces significant sedation and **anterograde amnesia**, making it useful as a pre-anesthetic medication. * **Mydriatic & Cycloplegic:** Like atropine, it causes pupillary dilation and paralysis of accommodation, but its duration of action is shorter (3–7 days) compared to atropine (7–10 days). * **Contraindication:** Like all muscarinic antagonists, it is strictly contraindicated in patients with **Angle-closure Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**.

Question 404: Which was the first neuromuscular blocker to be used clinically?

A. D-tubocurare (Correct Answer)
B. Succinylcholine
C. Doxacurium
D. Mivacurium

Explanation: **Explanation:** The correct answer is **D-tubocurare**. **1. Why D-tubocurare is correct:** D-tubocurare is a natural alkaloid derived from South American arrow poisons (Curare). It was the first neuromuscular blocking agent (NMBA) to be used clinically, introduced by **Griffith and Johnson in 1942** to provide muscle relaxation during anesthesia. It acts as a competitive (non-depolarizing) antagonist at the nicotinic acetylcholine receptors ($N_m$) of the motor endplate. **2. Why the other options are incorrect:** * **Succinylcholine:** This is a depolarizing NMBA. While it is the gold standard for rapid sequence induction due to its fast onset and short duration, it was introduced into clinical practice later (around 1951). * **Doxacurium:** This is a long-acting synthetic non-depolarizing NMBA belonging to the benzylisoquinolinium class. It was developed much later to provide cardiovascular stability without the histamine release seen with D-tubocurare. * **Mivacurium:** This is a short-acting benzylisoquinolinium NMBA. It is a modern drug metabolized by plasma cholinesterase, developed decades after D-tubocurare. **3. NEET-PG High-Yield Pearls:** * **Mechanism:** D-tubocurare causes histamine release (leading to hypotension and bronchospasm) and ganglion blockade. * **Reversal:** Its effects are reversed by acetylcholinesterase inhibitors like **Neostigmine**. * **Hoffman Elimination:** Remember that **Atracurium** and **Cisatracurium** are the NMBAs of choice in liver or kidney failure due to organ-independent metabolism (Hoffman elimination). * **Historical Note:** Claude Bernard (1850) first demonstrated that curare acts at the neuromuscular junction, not the nerve or muscle itself.

Question 405: Which of the following is a peripherally acting muscle relaxant?

A. Chlorzoxazone
B. Methocarbamol
C. Succinylcholine (Correct Answer)
D. Cortisopradol

Explanation: ### Explanation **Correct Answer: C. Succinylcholine** **Mechanism and Classification:** Muscle relaxants are broadly classified into two categories: **Peripherally acting** and **Centrally acting**. * **Peripherally acting relaxants** (Neuromuscular Blockers) act directly at the **Nicotinic-M (Nm) receptors** of the motor endplate in the neuromuscular junction (NMJ). * **Succinylcholine** is a depolarizing neuromuscular blocker. It mimics acetylcholine, causing persistent depolarization of the motor endplate, which leads to transient fasciculations followed by flaccid paralysis. Because its site of action is the NMJ (outside the CNS), it is a peripheral relaxant. **Analysis of Incorrect Options:** * **A. Chlorzoxazone:** This is a **centrally acting** muscle relaxant. It works by inhibiting polysynaptic reflex arcs at the level of the spinal cord and subcortical areas of the brain. * **B. Methocarbamol:** Another **centrally acting** agent used for acute musculoskeletal spasms. It causes general CNS depression rather than direct action on the muscle fiber or NMJ. * **D. Carisoprodol (misspelled as Cortisopradol):** This is a **centrally acting** sedative-relaxant. It is metabolized into meprobamate and acts primarily by modulating GABA-A receptors in the CNS. **High-Yield NEET-PG Pearls:** 1. **Succinylcholine** is the drug of choice for **Rapid Sequence Induction (RSI)** due to its fastest onset (30–60s) and shortest duration (5–10 mins). 2. It is metabolized by **Pseudocholinesterase** (Plasma cholinesterase). Patients with "Atypical Pseudocholinesterase" may experience prolonged apnea. 3. **Key Side Effects:** Hyperkalemia (avoid in burn/trauma patients), Malignant Hyperthermia (treated with **Dantrolene**), and muscle soreness. 4. **Dantrolene** is a unique peripheral relaxant that acts by blocking **Ryanodine receptors (RyR1)**, preventing calcium release from the sarcoplasmic reticulum.

Question 406: A specific compound is derived from a plant. What condition is this compound used to treat?

A. Glaucoma
B. Tachycardia
C. Hyperpyrexia
D. Iridocyclitis (Correct Answer)

Explanation: ***Iridocyclitis*** - **Atropine** from *Atropa belladonna* causes **mydriasis** and **cycloplegia**, preventing **posterior synechiae** formation in iridocyclitis. - It relieves **ciliary muscle spasm** and reduces pain associated with **iris inflammation**. *Glaucoma* - **Pilocarpine** or **physostigmine** (cholinergic agonists) are used for glaucoma to **constrict pupils** and increase aqueous humor outflow. - **Atropine** would worsen glaucoma by causing **mydriasis** and increasing **intraocular pressure**. *Tachycardia* - **Atropine** actually **causes tachycardia** by blocking **parasympathetic stimulation** of the heart. - It increases heart rate rather than treating elevated heart rate conditions. *Hyperpyrexia* - **Hyperpyrexia** is an **adverse effect** of atropine overdose due to impaired **thermoregulation**. - Atropine blocks **sweat glands** and can cause dangerous elevation in body temperature.

Question 407: Which of the following functions is NOT associated with anticholinergic drugs?

A. Antipruritic
B. Sedation
C. Decrease gastric acid secretion (Correct Answer)
D. Antivertiginous

Explanation: **Explanation:** The correct answer is **C. Decrease gastric acid secretion.** While classical anticholinergics (like Atropine) block M1 receptors on gastric parietal cells, they are **not clinically effective** for decreasing gastric acid secretion at standard doses. To achieve significant acid suppression, doses would need to be so high that they would cause intolerable side effects (dry mouth, blurred vision, tachycardia). Modern medicine uses Proton Pump Inhibitors (PPIs) or H2 blockers for this purpose. Note: While Pirenzepine is a selective M1 blocker that can reduce acid, it is rarely used clinically compared to superior alternatives. **Analysis of Other Options:** * **A. Antipruritic:** Anticholinergics (specifically older H1-antihistamines with strong anticholinergic properties like Diphenhydramine) are used to relieve itching due to their sedative and central effects. * **B. Sedation:** Many anticholinergics cross the blood-brain barrier and cause CNS depression, leading to drowsiness and sedation (e.g., Hyoscine/Scopolamine). * **C. Antivertiginous:** Anticholinergics are a mainstay in treating motion sickness and vertigo. They act on the vestibular apparatus and the vomiting center in the brain (e.g., Hyoscine patches). **NEET-PG High-Yield Pearls:** * **Mydriasis vs. Miosis:** Anticholinergics cause Mydriasis (dilation) and Cycloplegia (paralysis of accommodation). * **Drug of Choice:** Hyoscine (Scopolamine) is the DOC for motion sickness prophylaxis. * **Contraindication:** Always avoid anticholinergics in patients with **Angle-closure Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**. * **Antidote:** Physostigmine is used to treat central anticholinergic toxicity as it crosses the BBB.

Question 408: In which of the following conditions, anti-muscarinic drugs are to be avoided?

A. Glaucoma (Correct Answer)
B. Asthma
C. Peptic ulcer
D. Stress incontinence

Explanation: **Explanation:** **1. Why Glaucoma is the Correct Answer:** Anti-muscarinic drugs (like Atropine) are strictly contraindicated in **Angle-closure Glaucoma**. These drugs cause **mydriasis** (dilation of the pupil) by blocking the $M_3$ receptors on the iris sphincter muscle. When the iris dilates, the iris tissue folds and crowds the anterior chamber angle, obstructing the drainage of aqueous humor through the Canal of Schlemm. This leads to a rapid increase in intraocular pressure (IOP), which can precipitate an acute attack of glaucoma and lead to permanent vision loss. **2. Why the Other Options are Incorrect:** * **Asthma:** While anti-muscarinics (e.g., Ipratropium, Tiotropium) are not the first-line treatment for acute asthma, they are actually **used as bronchodilators** in COPD and refractory asthma. They are not contraindicated. * **Peptic Ulcer:** Anti-muscarinics (e.g., Pirenzepine) reduce gastric acid secretion by blocking $M_1$ receptors. While rarely used today due to the superiority of PPIs, they were historically a treatment modality, not a contraindication. * **Stress Incontinence:** Anti-muscarinics (e.g., Oxybutynin, Solifenacin) are the **treatment of choice for Urge Incontinence** (Overactive Bladder). While they don't treat stress incontinence (which is anatomical), they are not specifically contraindicated unless the patient has urinary retention. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Anti-cholinergic Contraindications:** "**ABCDEFG**" — **A**ngle-closure glaucoma, **B**enign Prostatic Hyperplasia (BPH), **C**onstipation/Chronic Atony, **D**ementia (worsens confusion), **E**lderly (high risk of delirium), **F**ever, **G**astric outlet obstruction. * **Drug of Choice for Mushroom Poisoning:** Atropine. * **Belladonna Poisoning Antidote:** Physostigmine (crosses BBB).

Question 409: A 60-year-old male requires an eye examination. Which drug can be used to dilate his pupils without causing paralysis of the ciliary muscles?

A. Atropine
B. Phenylephrine (Correct Answer)
C. Cyclopentolate
D. Tropicamide

Explanation: ### Explanation The correct answer is **Phenylephrine**. **1. Why Phenylephrine is correct:** To understand this, we must distinguish between **Mydriasis** (pupillary dilation) and **Cycloplegia** (paralysis of the ciliary muscle/loss of accommodation) [2]. * **Mechanism:** Phenylephrine is a selective **$\alpha_1$-adrenergic agonist**. It acts on the radial dilator pupillae muscle of the iris to cause contraction, resulting in mydriasis [1], [4]. * **The Key Concept:** Because the ciliary muscle (responsible for accommodation) is controlled by **muscarinic ($M_3$) receptors** and not alpha receptors, Phenylephrine does not affect the ciliary muscle [3], [4]. Therefore, it produces **mydriasis without cycloplegia** [4]. **2. Why the other options are incorrect:** * **Atropine, Cyclopentolate, and Tropicamide** are all **Muscarinic Antagonists (Anticholinergics)**. * They block $M_3$ receptors on both the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia) [2], [4]. * Using these drugs would result in a temporary loss of near vision, which the question specifically asks to avoid. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice for Fundus Examination:** **Tropicamide** is often preferred clinically because it has the shortest duration of action among anticholinergics (~6 hours), whereas Atropine can last 7–10 days. * **Phenylephrine Caution:** It should be avoided or used cautiously in patients with narrow-angle glaucoma and hypertension. * **Diagnostic Use:** Phenylephrine is also used to differentiate between scleritis and episcleritis (it blanches episcleral vessels). * **Mnemonic:** "A"nticholinergics cause "**A**"ccommodation loss; Sympathomimetics (like Phenylephrine) do not.

Question 410: Which of the following conditions is NOT treated with a cholinomimetic agent?

A. Bradycardia (Correct Answer)
B. Glaucoma
C. Myasthenia gravis
D. Post-surgical atony or ileus

Explanation: **Explanation:** Cholinomimetic agents (cholinergic agonists) mimic the action of acetylcholine (ACh) by stimulating muscarinic and nicotinic receptors. To answer this question, one must understand the physiological effects of Parasympathetic Nervous System (PNS) activation. **1. Why Bradycardia is the Correct Answer:** Stimulation of **M2 receptors** in the heart (specifically at the SA node) leads to a decrease in heart rate (negative chronotropy). Therefore, cholinomimetics would **worsen** bradycardia. In clinical practice, **anticholinergics** (like Atropine) are used to treat bradycardia, not cholinomimetics. **2. Why the other options are incorrect (Uses of Cholinomimetics):** * **Glaucoma:** Direct agonists like **Pilocarpine** cause miosis and contraction of the ciliary muscle, which opens the trabecular meshwork and facilitates the drainage of aqueous humor, reducing intraocular pressure. * **Myasthenia Gravis:** This condition involves autoantibodies against NMJ nicotinic receptors. Indirect cholinomimetics (AChE inhibitors) like **Pyridostigmine** or **Neostigmine** increase the concentration of ACh at the synaptic cleft, improving muscle strength. * **Post-surgical Atony/Ileus:** Drugs like **Bethanechol** (a muscarinic agonist) stimulate **M3 receptors** in the GI tract and bladder, promoting peristalsis and bladder emptying in non-obstructive conditions. **High-Yield NEET-PG Pearls:** * **Bethanechol:** "B" for Bowel and Bladder (used for postoperative ileus/urinary retention). * **Pilocarpine:** Drug of choice for acute angle-closure glaucoma. * **Edrophonium:** A short-acting AChE inhibitor used in the **Tensilon Test** for diagnosing Myasthenia Gravis (though largely replaced by antibody testing). * **Contraindications:** Cholinomimetics should be avoided in patients with **Asthma** (causes bronchoconstriction) and **Peptic Ulcer Disease** (increases gastric acid secretion).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free